IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.802
AS - Asia 5.407
EU - Europa 3.755
SA - Sud America 1.005
AF - Africa 320
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.641
SG - Singapore 2.374
CN - Cina 1.542
IE - Irlanda 826
BR - Brasile 824
IT - Italia 717
SE - Svezia 666
HK - Hong Kong 492
DE - Germania 383
VN - Vietnam 324
NL - Olanda 221
FR - Francia 217
ZA - Sudafrica 217
FI - Finlandia 207
TR - Turchia 181
RU - Federazione Russa 107
IN - India 104
CA - Canada 92
GB - Regno Unito 90
AR - Argentina 81
UA - Ucraina 75
AT - Austria 62
KR - Corea 60
BD - Bangladesh 52
JP - Giappone 45
MX - Messico 44
IQ - Iraq 41
CI - Costa d'Avorio 39
ID - Indonesia 33
BE - Belgio 31
PL - Polonia 31
CO - Colombia 22
PK - Pakistan 22
CZ - Repubblica Ceca 21
ES - Italia 21
EC - Ecuador 18
UZ - Uzbekistan 18
VE - Venezuela 18
LT - Lituania 14
MA - Marocco 14
CL - Cile 13
KE - Kenya 13
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
RO - Romania 10
EG - Egitto 9
IR - Iran 9
KZ - Kazakistan 9
MY - Malesia 9
DK - Danimarca 8
KH - Cambogia 7
PE - Perù 7
AU - Australia 6
CH - Svizzera 6
DZ - Algeria 6
IL - Israele 6
PA - Panama 6
TW - Taiwan 6
UY - Uruguay 6
AM - Armenia 5
DO - Repubblica Dominicana 5
EU - Europa 5
LU - Lussemburgo 5
OM - Oman 5
TH - Thailandia 5
TN - Tunisia 5
BG - Bulgaria 4
BY - Bielorussia 4
KG - Kirghizistan 4
LV - Lettonia 4
PS - Palestinian Territory 4
RS - Serbia 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
EE - Estonia 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
QA - Qatar 3
AO - Angola 2
BN - Brunei Darussalam 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LY - Libia 2
NP - Nepal 2
SA - Arabia Saudita 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
UG - Uganda 2
Totale 16.282
Salva come PNG Salva come JPEG
Città #
Singapore 1.177
Dublin 826
Ashburn 806
Chandler 620
Dallas 555
Santa Clara 544
Hong Kong 484
Beijing 388
Parma 224
Boardman 214
Johannesburg 202
Ann Arbor 201
Dearborn 191
Shanghai 171
New York 150
Princeton 147
Los Angeles 138
Izmir 131
Nanjing 119
Munich 116
Ho Chi Minh City 106
Wilmington 99
São Paulo 90
Hefei 88
Hanoi 83
Grafing 77
Helsinki 72
Jacksonville 69
Milan 69
Columbus 63
Moscow 59
Jinan 55
Seoul 54
Shenyang 51
Vienna 48
Des Moines 47
Bremen 43
Tokyo 43
Seattle 41
Abidjan 39
Buffalo 38
Tianjin 37
Chicago 36
Turku 36
Toronto 35
The Dalles 33
Hebei 32
Rio de Janeiro 32
Bengaluru 31
Kunming 31
Rome 31
Guangzhou 30
Kocaeli 30
Nuremberg 30
Bologna 29
Frankfurt am Main 29
Nanchang 28
Council Bluffs 27
Warsaw 26
Montreal 25
Changsha 24
Brooklyn 23
Brussels 23
Jakarta 23
Redmond 23
Ardea 22
Stockholm 22
Phoenix 21
Zhengzhou 21
Belo Horizonte 20
Jiaxing 20
London 19
Norwalk 18
San Mateo 18
Denver 17
Houston 17
Reggio Emilia 17
Chennai 16
Düsseldorf 16
Fairfield 15
Fremont 15
Hangzhou 15
Woodbridge 15
Atlanta 14
Boston 14
Mexico City 14
Salvador 14
Tashkent 14
Dhaka 13
Falls Church 13
Haiphong 13
Orem 13
Amsterdam 12
Baghdad 12
Istanbul 12
San Francisco 12
Baku 11
Brasília 11
Curitiba 11
Manchester 11
Totale 9.980
Salva come PNG Salva come JPEG
Nome #
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 255
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 254
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 235
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 225
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 200
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 191
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 179
A simplified sars-cov-2 pseudovirus neutralization assay 174
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 157
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 146
Metabolic regulation of the HBV-specific T cell function 145
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 142
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 136
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 134
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 133
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 131
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 131
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 130
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 130
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 129
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 129
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 129
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 129
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 128
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 126
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 125
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 124
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 123
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 123
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 122
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 122
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 121
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 121
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 120
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 119
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 119
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 119
HBV immune-therapy: From molecular mechanisms to clinical applications 118
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 117
T cell regulation in HBV-related chronic liver disease 117
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 116
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 115
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 115
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 114
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 111
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 110
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 109
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 105
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 103
The changing scenario of hepatocellular carcinoma in Italy: an update 103
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 102
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 102
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 101
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 101
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 101
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 98
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 98
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 98
Fine specificity of the human T cell response to hepatitis B virus core antigen 97
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 97
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 96
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 95
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use 95
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 95
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 95
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 95
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 94
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 93
AISF position paper on HCV in immunocompromised patients 93
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 93
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 93
[Surgical risks for cirrhotic patients] 93
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 92
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 91
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 91
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 90
Immune pathogenesis of hepatitis B 90
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 90
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 89
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 89
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 89
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 88
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 88
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 88
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 87
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 87
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 86
In reply 86
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 85
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 85
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 84
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 83
Metabolic disorders across hepatocellular carcinoma in Italy 83
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 82
Combination of radiofrequency ablation and immunotherapy 82
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 82
Comparative pathogenesis of HBV and HCV 81
High ASCT2 activity as a marker of extracellular glutamine dependence in ammoniagenic multiple myeloma cell lines 81
Hepatitis B Virus Maintains Its Pro-oncogenic Properties in the Case of Occult HBV Infection 81
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 81
Totale 11.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021500 0 0 0 0 0 53 72 72 144 70 54 35
2021/2022727 19 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/20241.260 72 122 42 57 113 292 85 88 46 74 92 177
2024/20254.417 91 221 279 233 492 548 224 198 576 421 361 773
2025/20265.040 830 877 1.142 850 1.268 73 0 0 0 0 0 0
Totale 16.604